Comments
Unichem Laboratories is recalling 96,876 bottles of Bisoprolol Fumarate tablets used for the treatment of hypertension from the US market.
Unichem Pharmaceuticals USA Inc is recalling the tablets in the strength of 5 mg manufactured by Unichem Laboratories at its Goa plant, USFDA said in its latest Enforcement Report.
The reason for the recall is “failed impurities/degradation specifications: out of specification for an unknown impurity was observed during the 18-month stability testing,” the report said.
The voluntary ongoing nationwide recall is a class II recall, it said.
As per USFDA, a class II recall is initiated in a “situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote''.
Unichem Pharmaceuticals USA, Inc is a wholly-owned subsidiary of Unichem Laboratories.
Shares of the company were trading higher by 9.83 per cent at Rs 286 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.